Xyphos (formerly AvidBiotics)
100 Kimball Way
South San Francisco, CA 94080-6218
Biotech and Pharmaceutical
Drug Discovery and Development
Pylum (formerly AvidBiotics) is a developer of novel, non-antibody proteins targeting bacteria, and virus infected cells. Pylum has has developed a new class of tailorable, targeted bactericidal agents for use in the treatment or prevention of specific bacterial infections or contaminations. Pylum focuses on human therapeutic applications of its technologies, both on its own and in partnership with governmental agencies and research institutions, while taking advantage of further near-term collaborative opportunities offered by specific applications of its products and technology platforms in areas such as food safety, biodefense and animal husbandry.